ASK REDCHAT ANYTHING ABOUT MONOPAR THERAPEUTICS INC.
Monopar Therapeutics Inc. (NASDAQ: MNPR)
Listen to this Section
$106.60
N/A
(
0% )
143.0K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| MNPR-101-ZrDetailsCancer |
Phase 1 |
| MNPR-101-RITDetailsCancer |
Phase 1 |
| MNPR-101-LuDetailsCancer |
Phase 1a |
| MNPR-101-ZrDetailsCancer, Solid tumor/s |
Phase 1 |
Market Data
|
| Open |
$106.60 |
| Previous Close |
$106.60 |
| Volume |
143.0K |
| Market Cap |
$714.12M |
| Day Range |
$98.53 - $107.97 |
| 52 Week Range |
$29.18 - $112.57 |
| Shares Outstanding |
6.70M |
| Change % |
0% |
| Net Change |
N/A |
| Insider Ownership |
-0.14% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2019 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-388,247.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-10-30 |
Buy |
1550.00 |
Radhakrishnan Karthik |
| 2024-07-03 |
Sale |
-125000.00 |
Radhakrishnan Karthik |
| 2024-07-02 |
Sale |
-8952.00 |
Cittadine Andrew |
| 2024-07-02 |
Sale |
-24476.00 |
Robinson Chandler |
| 2024-07-02 |
Sale |
-9957.00 |
Tsuchimoto Kim R |
| 2024-06-21 |
Buy |
12000.00 |
Cittadine Andrew |
| 2024-06-17 |
Buy |
12000.00 |
Cittadine Andrew |
| 2024-06-05 |
Buy |
12000.00 |
Cittadine Andrew |
| 2024-05-31 |
Buy |
12000.00 |
Cittadine Andrew |
| 2024-05-30 |
Sale |
-84000.00 |
Robinson Chandler |